Treace Medical Concepts, Inc.
TMCI • NASDAQ
Treace Medical Concepts, Inc. is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO John T. Treace, with a market cap of $78.8M.
CEOJohn T. Treace
Next Earnings
Upcoming earnings announcement for Treace Medical Concepts, Inc.
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.29
Revenue Estimate
$46.0M
Earnings History
Past 12 earnings reports for Treace Medical Concepts, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 27, 2026 | Q4 2025 | -$0.15Est: -$0.14 | -7.1% | $62.5MEst: $61.8M | +1.1% |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.26Est: -$0.27 | +3.7% | $50.2MEst: $49.6M | +1.2% | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.28Est: -$0.29 | +3.4% | $47.4MEst: $47.1M | +0.7% | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.25Est: -$0.30 | +16.7% | $52.6MEst: $52.7M | -0.2% | 10-Q |
| Feb 27, 2025 | Q4 2024 | -$0.01Est: -$0.04 | +75.0% | $68.7MEst: $67.2M | +2.3% | 10-K |
| Nov 5, 2024 | Q3 2024 | -$0.25Est: -$0.27 | +7.4% | $45.1MEst: $43.5M | +3.7% | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$0.34Est: -$0.29 | -17.2% | $44.5MEst: $43.0M | +3.4% | 10-Q |
| May 7, 2024 | Q1 2024 | -$0.30Est: -$0.30 | 0.0% | $51.1MEst: $49.1M | +4.2% | 10-Q |
| Feb 27, 2024 | Q4 2023 | -$0.10Est: -$0.09 | -11.1% | $62.2MEst: $60.6M | +2.7% | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.28Est: -$0.26 | -7.7% | $40.8MEst: $42.1M | -3.1% | — |
| Aug 8, 2023 | Q2 2023 | -$0.20Est: -$0.24 | +16.7% | $42.0MEst: $40.9M | +2.7% | 10-Q |
| May 8, 2023 | Q1 2023 | -$0.23Est: -$0.23 | 0.0% | $42.2MEst: $39.2M | +7.5% | — |